id	keyword
bjp-27384	cancer
bjp-27384	breast
bjp-27384	risk
bjp-27384	trastuzumab
bjp-27384	her2
bjp-27384	breast cancer
bjp-27384	neoadjuvant
bjp-27384	lapatinib
bjp-27384	chemotherapy
bjp-27384	study
